Hydronidone

羟尼酮

Report date: 2026/05/13 15:18:19
NME

Base Information

Drug NameHydronidone
Drug Alias NameF-351
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCollagen inhibitorsFibroblast growth factors antagonists
TargetsCollagenFibroblast growth factors
Therapy Area/IndicationsFibrosisRenal Insufficiency, ChronicLiver Cirrhosis +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesShanghai Genomics Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGyre Therapeutics IncBeijing Continent Pharmaceutical Co Ltd
Inactive CompaniesShanghai Genomics Inc
Active IndicationsRenal Insufficiency, ChronicLiver CirrhosisHepatitis B, Chronic +[4] 
Inactive IndicationsFibrosisHepatic InsufficiencyLiver Diseases

Other Information

ATC CodeN/A
Related LinksDrugBank